Ownership and insider activity for Creative Medical Technology Holdings, Inc. (CELZ): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology.
Price
| Price | $0.82 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2025-02-18 | Finger Michael H. | S-Sale | 750 | $4K |
| 2025-02-19 | Finger Michael H. | S-Sale | 750 | $4K |
| 2023-06-28 | Warbington Timothy | P-Purchase | 200 | $872 |
| 2023-06-27 | Warbington Timothy | P-Purchase | 200 | $896 |
| 2023-06-27 | Warbington Timothy | P-Purchase | 300 | $1K |
| 2023-06-27 | Warbington Timothy | P-Purchase | 300 | $1K |
| 2022-11-22 | Warbington Timothy | P-Purchase | 200 | $75 |
| 2022-11-22 | Warbington Timothy | P-Purchase | 9,800 | $4K |
| 2022-11-21 | Warbington Timothy | P-Purchase | 5,000 | $2K |
| 2022-11-21 | Warbington Timothy | P-Purchase | 10,000 | $4K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $221868 | $13697 | $304056 | $88648 | $98012 | $10.7M | $8.3M | $3.5M | $5.9M | $7.2M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | $10.1M | $6.5M | 0 | 0 |
| Receivables | 0 | $4801 | $9600 | $5600 | 0 | $2485 | 0 | 0 | 0 | $52084 |
| Inventory | 0 | 0 | 0 | 0 | 0 | $10866 | $10194 | $6594 | $2194 | 0 |
| Total Current Assets | $221868 | $18498 | $313656 | $94248 | $98012 | $10.7M | $18.7M | $10.3M | $6.1M | $7.4M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $100644 | $184649 | $163505 | $436555 | $619763 | $527679 | $435595 | $441011 | $530559 | $407230 |
| Total Assets | $322512 | $203147 | $477161 | $530803 | $717775 | $11.3M | $19.2M | $10.7M | $6.7M | $7.8M |
| Accounts Payable | $66385 | $237566 | $331838 | $320785 | $350899 | $761862 | $3.3M | $317280 | $273530 | $270686 |
| Short-term Debt | $102600 | $501748 | $682056 | $1.1M | $788701 | 0 | 0 | 0 | 0 | $14194 |
| Total Current Liabilities | $453864 | $2.4M | $4.5M | $8.6M | $40.5M | $1.1M | $3.3M | $371394 | $327644 | $284880 |
| Long-term Debt | $25000 | $915 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $480303 | $2.4M | $4.5M | $8.6M | $40.5M | $1.1M | $3.3M | $371394 | $327644 | $284880 |
| Retained Earnings | -$766572 | -$3.4M | -$17.1M | -$25.6M | -$61.9M | -$43.7M | -$53.8M | -$59.1M | -$64.6M | -$70.6M |
| Total Equity | -$157791 | -$2.2M | -$4.0M | -$8.1M | -$39.8M | $10.2M | $15.9M | $10.3M | $6.3M | $7.5M |
| Total Debt | $125000 | $513463 | $682056 | $1.1M | $788701 | 0 | 0 | 0 | 0 | $14194 |
| Net Debt | -$96868 | $499766 | $378000 | $973618 | $690689 | -$10.7M | -$18.4M | -$10.0M | -$5.9M | -$7.2M |
| Working Capital | -$231996 | -$2.4M | -$4.2M | -$8.5M | -$40.4M | $9.7M | $15.4M | $9.9M | $5.8M | $7.1M |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 12.91 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -4.32 |
Profitability
| Return on Equity | -86.70% |
| Return on Invested Capital | -71.90% |
| Return on Assets | -64.42% |
| Gross Margin | -1732.37% |
| Operating Margin | -208004.40% |
| Net Margin | -201355.37% |
Related companies: ACXP · ADIL · ADXN · ALZN · APRE · BCDA · CDIO
Explore sector: Healthcare · Biotechnology
More sections of CELZ: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks